Satoshi Morita

Profile Information

Affiliation: Professor, Department of Biomedical Statistics and Bioinformatics, Kyoto University

J-GLOBAL ID: 201201070973864612
researchmap Member ID: 7000002723

Research Areas

Other / Other /

Papers

650

Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.

Don Pietro Saldajeno, Shinpei Kawaoka, Norikazu Masuda, Sunao Tanaka, Hiroko Bando, Tomomi Nishimura, Takayuki Kadoya, Takashi Yamanaka, Shigeru Imoto, Ravindranath M Velaga …

British journal of cancer, Jan 18, 2024
Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis.

Ayane Yamaguchi, Kosuke Kawaguchi, Kana Kawanishi, Yurina Maeshima, Akiyoshi Nakakura, Tatsuki R Kataoka, Sachiko Takahara, Shunsaku Nakagawa, Atsushi Yonezawa, Masahiro Takada …

Breast cancer research and treatment, Dec 21, 2023
乳癌免疫療法の課題と展望免疫療法としてのCDK4/6阻害薬腸内細菌叢と循環免疫プロファイルの観点から

河口浩介, 前島佑里奈, 藤本優里, 石黒洋, 山神和彦, 高原祥子, 諏訪裕文, 鳥井雅恵, 永井成勲, 相良安昭 …

日本乳癌学会総会プログラム抄録集, 31回 19-19, Jun, 2023
Comprehensive data of 4502 patients newly diagnosed with colorectal liver metastasis between 2015 and 2017, and prognostic data of 2427 patients newly diagnosed with colorectal liver metastasis in 2013 and 2014: Third report of a nationwide survey in Japan.

Katsunori Sakamoto, Toru Beppu, Goro Honda, Kenjiro Kotake, Masakazu Yamamoto, Keiichi Takahashi, Itaru Endo, Kiyoshi Hasegawa, Michio Itabashi, Yojiro Hashiguchi …

Journal of hepato-biliary-pancreatic sciences, 30(5) 570-590, May, 2023
Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312)

Nobuyuki Katakami, Takashi Nishimura, Yu Hidaka, Akito Hata, Kazumi Nishino, Masahide Mori, Tomonori Hirashima, Naoto Takase, Toshihiko Kaneda, Hisashi Ohnishi …

Lung Cancer, 107261-107261, May, 2023
Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study.

Satoru Iwasa, Zi-Xian Wang, Kei Muro, Satoshi Morita, Young Suk Park, Dongsheng Zhang, Yasuhide Yamada, Junichi Sakamoto, Tae Won Kim

Cancer communications (London, England), 43(4) 519-522, Apr, 2023
Phase Ib/II study of nivolumab combined with palliative radiation therapy for bone metastasis in patients with HER2-negative metastatic breast cancer

Masahiro Takada, Michio Yoshimura, Takeshi Kotake, Kosuke Kawaguchi, Ryuji Uozumi, Masako Kataoka, Hironori Kato, Hiroshi Yoshibayashi, Hirofumi Suwa, Wakako Tsuji …

Scientific Reports, 12(1), Dec 27, 2022
Sleep disordered breathing and haemoglobin A1c levels within or over normal range and ageing or sex differences: the Nagahama study.

Takeshi Matsumoto, Kimihiko Murase, Yasuharu Tabara, Takuma Minami, Osamu Kanai, Hirofumi Takeyama, Hironobu Sunadome, Tadao Nagasaki, Naomi Takahashi, Yoshinari Nakatsuka …

Journal of sleep research, 32(3) e13795, Nov 27, 2022
Overall survival analysis of patients enrolled in a randomized phase III trial comparing gefitinib and erlotinib for previously treated advanced lung adenocarcinoma (WJOG5108LFS).

Nobuyuki Katakami, Toshihide Yokoyama, Satoshi Morita, Tatsuro Okamoto, Yoshiko Urata, Yoshihiro Hattori, Yasuo Iwamoto, Yuki Sato, Norihiko Ikeda, Toshiaki Takahashi …

International journal of clinical oncology, 28(1) 79-88, Nov 21, 2022
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial

Keiko Imamura, Yuishin Izumi, Makiko Nagai, Kazutoshi Nishiyama, Yasuhiro Watanabe, Ritsuko Hanajima, Naohiro Egawa, Takashi Ayaki, Ryosuke Oki, Koji Fujita …

eClinicalMedicine, 101707-101707, Oct, 2022
Multimodal telemonitoring for weight reduction in sleep apnea patients: A randomized controlled trial.

Kimihiko Murase, Takuma Minami, Satoshi Hamada, David Gozal, Naomi Takahashi, Yoshinari Nakatsuka, Hirofumi Takeyama, Kiminobu Tanizawa, Daisuke Endo, Toshiki Akahoshi …

Chest, 162(6) 1373-1383, Aug 20, 2022
Laparoscopic Versus Open Surgery for Locally Advanced Rectal Cancer: Five-Year Survival Outcomes in a Large, Multicenter, Propensity Score-Matched Cohort Study.

Daisuke Nishizaki, Koya Hida, Atsuhiko Sumii, Ryosuke Okamura, Yoshiharu Sakai, Tsuyoshi Konishi, Takashi Akiyoshi, Satoshi Maruyama, Masazumi Okajima, Yasuyuki Miyakura …

Diseases of the colon and rectum, 65(8) 1005-1014, Aug 1, 2022
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).

Yutaka Yamamoto, Hiroji Iwata, Naruto Taira, Norikazu Masuda, Masato Takahashi, Tetsuhiro Yoshinami, Takayuki Ueno, Tatsuya Toyama, Takashi Yamanaka, Toshimi Takano …

Cancer science, 113(9) 3169-3179, Jun 26, 2022
TNBCにおける時系列的なサイトカインプロファイルと治療効果およびHRDの相関性(Time-series cytokine profiles correlate with treatment responses and HRD in TNBC)

河口浩介, Saldajeno Don Pietro, 河岡慎平, 田中直, 坂東裕子, 西村友美, 角舎学行, 山中隆司, 井本滋, Velaga Ravi …

日本乳癌学会総会プログラム抄録集, 30回 OS2-3, Jun, 2022
A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study.

Masaru Matsumura, Kiyoshi Hasegawa, Masaru Oba, Kensei Yamaguchi, Hiroyuki Uetake, Takayuki Yoshino, Satoshi Morita, Keiichi Takahashi, Michiaki Unno, Yasuhiro Shimada …

Langenbeck's archives of surgery, 407(4) 1345-1356, Jun, 2022
Multi-institutional phase II study on the safety and efficacy of dynamic tumor tracking-stereotactic body radiotherapy for lung tumors.

Yukinori Matsuo, Masahiro Hiraoka, Katsuyuki Karasawa, Masaki Kokubo, Takashi Sakamoto, Nobutaka Mukumoto, Mitsuhiro Nakamura, Satoshi Morita, Takashi Mizowaki

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 172 18-22, May 2, 2022
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.

Shigehira Saji, Naruto Taira, Masahiro Kitada, Toshimi Takano, Masahiro Takada, Tohru Ohtake, Tatsuya Toyama, Yuichiro Kikawa, Yoshie Hasegawa, Tomomi Fujisawa …

The Lancet. Oncology, 23(5) 636-649, May, 2022
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.

Takayuki Ueno, Shigehisa Kitano, Norikazu Masuda, Daiki Ikarashi, Makiko Yamashita, Tomohiro Chiba, Takayuki Kadoya, Hiroko Bando, Takashi Yamanaka, Shoichiro Ohtani …

BMC medicine, 20(1) 136-136, Apr 25, 2022
No impact of donor sex on the recurrence of hepatocellular carcinoma after liver transplantation

Kojiro Taura, Tsuyoshi Shimamura, Nobuhisa Akamatsu, Koji Umeshita, Masato Fujiyoshi, Hiroyasu Abe, Satoshi Morita, Shinji Uemoto, Susumu Eguchi, Hiroyuki Furukawa …

Journal of Hepato-Biliary-Pancreatic Sciences, Mar 22, 2022
International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1).

Kazuhiro Yoshida, Itaru Yasufuku, Masanori Terashima, Sun Young Rha, Jae Moon Bae, Guoxin Li, Hitoshi Katai, Masahiko Watanabe, Yasuyuki Seto, Sung Hoon Noh …

Annals of gastroenterological surgery, 6(2) 227-240, Mar, 2022

Misc.

299

気管支喘息(成人) 管理:合併症,COVID-19 中高年発症喘息と睡眠呼吸障害の関係ながはまスタディ

砂留広伸, 松本久子, 村瀬公彦, 田原康玄, 西健太, 寺田悟, 野村奈都子, 古郷摩利子, 田嶋範之, 森本千絵 …

アレルギー, 70(6-7) 804-804, Aug, 2021
気管支喘息(成人) 管理:合併症,COVID-19 中高年発症喘息と睡眠呼吸障害の関係ながはまスタディ

砂留広伸, 松本久子, 村瀬公彦, 田原康玄, 西健太, 寺田悟, 野村奈都子, 古郷摩利子, 田嶋範之, 森本千絵 …

アレルギー, 70(6-7) 804-804, Aug, 2021
睡眠呼吸障害のバイオマーカーとしての血清尿酸値の有用性の検討ながはまスタディ

砂留広伸, 村瀬公彦, 田原康玄, 南卓馬, 武山博文, 高橋順美, 松本健, 濱田哲, 長崎忠雄, 谷澤公伸 …

日本呼吸器学会誌, 10(増刊) 206-206, Apr, 2021
睡眠時無呼吸患者に対する遠隔モニタリングシステムを利用した体重減量指導の効果多施設共同無作為化比較試験

村瀬公彦, 陳和夫, 赤星俊樹, 津田徹, 大井元晴, 外山善朗, 成井浩司, 富田康弘, 大平徹郎, 葛西隆敏 …

日本呼吸器学会誌, 10(増刊) 206-206, Apr, 2021
A randomized, open-label, phase III trial of pertuzumab re-treatment in HER2-positive, locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab, and chemotherapy: The Japan Breast Cancer Research Group-M05 (PRECIOUS) study

Yutaka Yamamoto, Hiroji Iwata, Taira Naruto, Norikazu Masuda, Masato Takahashi, Tetsuhiro Yoshinami, Takayuki Ueno, Tatsuya Toyama, Takashi Yamanaka, Toshimi Takano …

CANCER RESEARCH, 81(4), Feb, 2021
The effect of telemonitoring of weight on its reduction in sleep apnea patients: Multicenter randomized trial

村瀬公彦, 陳和夫, 赤星俊樹, 津田徹, 大井元晴, 外山善朗, 成井浩司, 富田康弘, 大平徹郎, 葛西隆敏 …

日本呼吸器学会誌(Web), 10, 2021
Predicting the efficacy of nivolumab combined with radiation therapy by longitudinal liquid biopsy with artificial intelligence for patients with metastatic breast cancer (translational research of the KBCRN-B-002 trial).

Kosuke Kawaguchi, Masahiro Takada, Takeshi Kotake, Michio Yoshimura, Ryuji Uozumi, Masako Kataoka, Takahiko Koyama, Reitaro Tokumasu, Hironori Kato, Hiroshi Yoshibayashi …

JOURNAL OF CLINICAL ONCOLOGY, 38(15), May, 2020
Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy.

Nahomi Tokudome, Yasuhiro Koh, Hiroaki Akamatsu, Daichi Fujimoto, Isamu Okamoto, Kazuhiko Nakagawa, Toyoaki Hida, Fumio Imamura, Satoshi Morita, Nobuyuki Yamamoto

BMC cancer, 20(1) 103-103, Feb 6, 2020
Alteration of the tumor immune microenvironment signatures by nivolumab combined with radiation therapy for patients with metastatic breast cancer (Translational Research of the KBCRN-B-002 trial)

Kosuke Kawaguchi, Masahiro Takada, Takeshi Kotake, Michio Yoshimura, Ryuji Uozumi, Masako Kataoka, Takahiko Koyama, Reitaro Tokumasu, Maya Honda, Rikiya Yamashita …

CANCER RESEARCH, 80(4), Feb, 2020
Addition of capecitabine to maintenance endocrine therapy after induction therapy with bevacizumab plus paclitaxel in hormone receptor positive and HER2 negative metastatic breast cancer (KBCSG-TR1214)

Tetsuhiro Yoshinami, Takahiro Nakayama, Masahiko Ikeda, Makiko Mizutani, Miki Yamaguchi, Yoshifumi Komoike, Tsutomu Takashima, Katsuhide Yoshidome, Junji Tsurutani, Mitsuhiko Iwamoto …

CANCER RESEARCH, 80(4), Feb, 2020
A multicenter phase Ib/II study for evaluating safety and efficacy of Nivolumab in combination with radiation therapy in patients with HER2-negative metastatic breast cancer (KBCRN-B-002 trial)

Masahiro Takada, Michio Yoshimura, Kosuke Kawaguchi, Takeshi Kotake, Ryuji Uozumi, Masako Kataoka, Takahiko Koyama, Hironori Kato, Hiroshi Yoshibayashi, Hirofumi Suwa …

CANCER RESEARCH, 80(4), Feb, 2020
Sleep disordered breathing shows different associations with atherosclerosis depending on the number of comorbidities~Nagahama Study~

中塚賀也, 村瀬公彦, 濱田哲, 武山博文, 松本健, 高橋順美, 谷澤公伸, 半田知宏, 田原康玄, 平井豊博 …

日本呼吸器学会誌(Web), 9, 2020
Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients.

Keiko Imamura, Yuishin Izumi, Haruhiko Banno, Ryuji Uozumi, Satoshi Morita, Naohiro Egawa, Takashi Ayaki, Makiko Nagai, Kazutoshi Nishiyama, Yasuhiro Watanabe …

BMJ open, 9(12) e033131, Dec 2, 2019
IB〜IIIA期肺癌切除例に対するCBDCA/PTXとUFTによる術後補助療法のランダム化比較試験(SLCG0401試験)の病期・組織型別のサブ解析

宗淳一, 豊岡伸一, 奥村典仁, 中村廣繁, 中田昌男, 山下素弘, 青江基, 堀田勝幸, 吉岡弘鎮, 伊達洋至 …

肺癌, 59(4) 425-425, Aug, 2019
進行卵巣癌に対するWT1を標的とした癌ワクチンに関する臨床研究(Clinical Study of the Cancer Vaccine targeting WT1 for Advanced Ovarian Cancer)

西田純幸, 白方俊章, 森本創世子, 榎本隆之, 吉野潔, 冨松拓治, 藤木文博, 尾路祐介, 上田豊, 坪井昭博 …

日本がん免疫学会総会プログラム・抄録集, 23回 159-159, Jul, 2019
持続陽圧(CPAP,ASV)治療管理開始時からの治療状況確認と自己学習を含めた患者・医療機関相互方向の遠隔医療の試み持続気道陽圧(CPAP)療法中の睡眠時無呼吸患者の肥満に対する遠隔モニタリングシステムを利用した減量指導の検証

巽浩一郎, 平井豊博, 森田智視, 大平徹郎, 坪井知正, 富井啓介, 葛西隆敏, 千葉伸太郎, 黒田知宏, 中山健夫 …

持続陽圧(CPAP、ASV)治療管理開始時からの治療状況確認と自己学習を含めた患者・医療機関相互方向の遠隔医療の試み平成30年度研究報告書(Web), 2019
Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer.

Takaki Yoshikawa, Toru Aoyama, Kentaro Sakamaki, Takasi Oshima, Joyce Lin, Shenli Zhang, Nur Sabrina Sapari, Richie Soong, Iain Tan, Xiu Bin Chan …

Journal of Cancer, 10(21) 5130-5138, 2019
非小細胞肺癌完全切除例に対する術後補助化学療法におけるERCC1の効果予測因子としての意義

中田昌男, 最相晋輔, 宗淳一, 奥村典仁, 中村廣繁, 山下素弘, 多田弘人, 森田智視, 豊岡伸一, 伊達洋至 …

肺癌, 58(6) 516-516, Oct, 2018
Global phase III trial of comparing mXELIRI plus BV vs FOLFIRI+Bmab for 2nd line mCRC (AXEPT) Japanese population analysis

Takeshi Kato, Yoshinori Kagawa, Mitsuyoshi Ota, Akitaka Makiyama, Tadamichi Denda, Chu Matsuda, Yasuhide Yamada, Satoru Iwasa, Tae Won Kim, Rui-hua Xu …

ANNALS OF ONCOLOGY, 29 65-65, Oct, 2018
Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study.

Shuichi Mizuta, Masashi Sawa, Hisashi Tsurumi, Kana Matsumoto, Kotaro Miyao, Takeshi Hara, Takeshi Takahashi, Reona Sakemura, Hiroshi Kojima, Akio Kohno …

International journal of clinical oncology, 23(5) 980-988, Oct, 2018

Books and Other Publications

Encyclopedia of Biopharmaceutical Statistics, 3rd Edition

MORITA Satoshi (Role: Contributor, Prior Effective Sample Size of a Bayesian Model.)

Informa Healthcare, 2010
消火器癌化学療法

森田智視 (Role: Contributor, 抗癌剤の臨床第Ⅱ,Ⅲ相試験)

南山堂, 2009
QOL評価学‐測定, 解析, 解釈のすべて

森田智視 (Role: Joint translator)

中山書店, 2005
癌治療の新たな試み新編III

森田智視 (Role: Contributor, QOL評価)

医薬ジャーナル社, 2005
腎臓病: 先端医療シリーズ

森田智視 (Role: Contributor, 予後予測因子としての健康関連QOL)

先端医療技術研究所, 2005
Handbook of Statistics in Clinical Oncology, Second Edition.

MORITA Satoshi (Role: Contributor, Practical Implementation of the Continual Reassessment Method.)

CRC Press, 2005
実践医学統計学

森田智視 (Role: Joint translator)

朝倉書店, 2004
医学統計のための線型混合効果モデル－SASによるアプローチ－

森田智視 (Role: Joint translator)

サイエンティスト社, 2001
新QOL調査票と評価の手引き

森田智視 (Role: Contributor, 臨床比較試験におけるQOLデータの解析)

メディカルレビュー社, 2001
臨床のためのQOL評価ハンドブック

森田智視 (Role: Contributor, QOLの統計学的評価)

医学書院, 2001
シナリオで学ぶ医療経済学入門

森田智視 (Role: Joint translator)

サイエンティスト社, 2000

Presentations

Bayesian Population Finding (BaPoFi) with Biomarkers in a Randomized Clinical Trial.

MORITA Satoshi

CEN-ISBS Conference, Aug, 2017
Incorporating historical data in Bayesian phase I trial design: The Caucasian-to-Asian toxicity tolerability problem

MORITA Satoshi

The Ninth ICSA International Conference, Dec, 2013
Bridging dose-finding for a multinational cancer phase I trial

MORITA Satoshi

Society for Clinical Trials 34th Annual Meeting, May, 2013
Bayesian study designs for new drug development

MORITA Satoshi

ISBA 2012 World Meeting, 2012
Sequential dose-finding in phase I clinical trials in Japan: East meets West

MORITA Satoshi

The 2011 Society for Clinical Trials Meeting, 2011
Bridging dose-finding studies from West to East.

MORITA Satoshi

The 2nd CRM Workshop, 2011
Practical Application of the Continual Reassessment Method to a Phase I Dose-Finding Trial in Japan: East meets West

MORITA Satoshi

The 1st CRM Workshop, Oct, 2009

Research Projects

Cross-sectional and prospective study with metabolome analysis to detect pathophysiology about the relationship between deterioration in lung function and sleep disordered breathing

Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (B), Japan Society for the Promotion of Science, Apr, 2020 - Mar, 2023
Design and statistical analysis in translational clinical trials

Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (A), Japan Society for the Promotion of Science, Apr, 2012 - Mar, 2016

Matsui Shigeyuki, YAMAGUCHI Takuhiro, FUJISAWA Hironori, DAIMON Takashi, SOZU Takashi, KAWAGUCHI Atsushi, ITO Yoichi, YAMANAKA Takeharu, HIRAKAWA Akihiro, NOMA Hisashi
Bayesian study designs for new drug development in early-stage cancer clinical trials.

Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, Apr, 2012 - Mar, 2015

MORITA Satoshi, DAIMON Takashi, TERAMUKAI Satoshi, TOI Masakazu, THALL Peter F.
A randomized controlled trial to establish a standard method for reconstruction after total gastrectomy

Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, 2011 - 2013

KODERA Yasuhiro, MORITA Satoshi, YOSHIKAWA Takaki, ITO Yuichi
Design and analysis of clinical studies for personalized medicine

Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, 2008 - 2010

MATSUI Shigeyuki, MORITA Satoshi, YAMANAKA Takeharu, DAIMON Takashi

Profile Information

Research Areas

Papers

Misc.

Books and Other Publications

Presentations

Research Projects

Menu

Coauthors